ID   MZ611ATRT
AC   CVCL_D4ZG
DR   Wikidata; Q127382913
RX   PubMed=38329694;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=38329694).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.541delC; Zygosity=Heterozygous (PubMed=38329694).
CC   Derived from site: In situ; Brain, quadrigeminal cistern; UBERON=UBERON_0004052.
ST   Source(s): PubMed=38329694
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9,10
ST   D21S11: 30
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=38329694; DOI=10.1007/s13577-023-01022-1;
RA   Matsumoto F., Yokogami K., Yamada A., Moritake H., Watanabe T.,
RA   Yamashita S., Sato Y., Takeshima H.;
RT   "Targeting cholesterol biosynthesis for AT/RT: comprehensive
RT   expression analysis and validation in newly established AT/RT cell
RT   line.";
RL   Hum. Cell 37:523-530(2024).
//